Wild and vaccine-derived poliovirus circulation, and implications for polio eradication

Epidemiology and Infection

Volumn 145, Issue 3, 2017, Pages 413-419

  Lopalco, P L ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Disease eradication; poliomyelitis; poliovirus; poliovirus vaccines

Indexed keywords

ORAL POLIOMYELITIS VACCINE; POLIOMYELITIS VACCINE; VIRUS ANTIBODY;

ENVIRONMENTAL FACTOR; EPIDEMIC; GEOGRAPHIC DISTRIBUTION; HEALTH CARE POLICY; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; IMMUNE RESPONSE; INFECTION CONTROL; INFECTION RISK; PAKISTAN; POLIOMYELITIS; PUBLIC HEALTH; PUBLIC HEALTH SERVICE; REVIEW; RISK ASSESSMENT; VIRAL CLEARANCE; VIRUS TRANSMISSION; AFGHANISTAN; BLOOD; CLASSIFICATION; DISEASE ERADICATION; IMMUNOLOGY; ISOLATION AND PURIFICATION; NIGERIA; POLIOMYELITIS VIRUS; VIROLOGY;

AFGHANISTAN; ANTIBODIES, VIRAL; DISEASE ERADICATION; HEALTH POLICY; HUMANS; NIGERIA; PAKISTAN; POLIOMYELITIS; POLIOVIRUS; POLIOVIRUS VACCINE, INACTIVATED; POLIOVIRUS VACCINE, ORAL;

EID: 84995770322     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268816002569     Document Type: Review

References (35)

1. Polio Global Eradication Initiative. Global eradication of wild poliovirus type 2 declared (http://www.polioeradication. org/mediaroom/newsstories/Global-eradicationofwild-poliovirus-type-2-declared/tabid/526/news/1289/ Default.aspx#sthash.TWdccMBL.dpuf). Accessed 31 May 2016
2. Polio Global Eradication Initiative. Wild poliovirus type 1 and circulating vaccine-derived poliovirus cases (http://www.polioeradication.org/Dataandmonitoring/ Poliothisweek.aspx#sthash.1c5 0b7hA.dpuf). Accessed 21 September 2016
3. Minor PD. The molecular biology of polio vaccines. Journal of General Virology 1992; 73: 3065-3077
4. Fine PEM, Carneiro IAM. Transmissibility and persistence of oral polio vaccine viruses: implications for the global poliomyelitis eradication initiative. American Journal of Epidemiology 1999; 150: 1001-1021
5. Martin J. Vaccine-derived poliovirus from long term excretors and the endgame of polio eradication. Biologicals 2006; 34: 117-122
6. Abraham R, et al. Shedding of virulent poliovirus revertants during immunization with oral poliovirus vaccine after prior immunization with inactivated polio vaccine. Journal of Infectious Diseases 1993; 168: 1105-1109
7. Minor P. Vaccine-derived poliovirus (VDPV): impact on poliomyelitis eradication. Vaccine 2009; 27: 2649-2652
8. Platt LR, Estívariz CF, Sutter RW. Vaccine-associated paralytic poliomyelitis: a review of the epidemiology and estimation of the global burden. Journal of Infectious Diseases 2014; 210 (Suppl. 1): S380-389
9. Korotkova EA, et al. A cluster of paralytic poliomyelitis cases due to transmission of slightly diverged Sabin-2 vaccine virus. Journal of Virology 2016; 90: 5978-5988
10. Wassilak S, et al. Outbreak of type 2 vaccine-derived poliovirus in Nigeria: Emergence and widespread circulation in an underimmunized population. Journal of Infectious Diseases 2011; 203: 898-909
11. CDC. Update on vaccine-derived polioviruses worldwide, January 2008-June 2009. Morbidity and Mortality Weekly Report 2009; 58: 1002-1006
12. Liu H-M, et al. Serial recombination during circulation of type 1 wild-vaccine recombinant polioviruses in China. Journal of Virology 2003; 77: 10994-11005
13. Combelas N, et al. Recombination between poliovirus and coxsackie a viruses of species C: a model of viral genetic plasticity and emergence. Viruses 2011; 3: 1460-1484
14. Burns CC, et al. Vaccine-derived polioviruses. Journal of Infectious Diseases 2014; 210 (Suppl. 1): S283-S293
15. CDC. Public Health Dispatch: Update: outbreak of poliomyelitis-Dominican Republic and Haiti, 2000-2001. Morbidity and Mortality Weekly Report 2001; 50: 855-856
16. Wringe A, et al. Estimating the extent of vaccine-derived poliovirus infection. PLoS ONE 2008; 3: e3433
17. Yang CF, et al. Circulation of endemic type 2 vaccinederived poliovirus in Egypt from 1983 to 1993. Journal of Virology 2003; 77: 8366-8377
18. Polio Global Eradication Initiative. Circulating vaccinederived polioviruses. (http://www.polioeradication.org/ Dataandmonitoring/Poliothisweek/Circulatingvaccine derivedpoliovirus.aspx). Accessed 30 May 2016
19. Morales M, Tangermann RH, Wassilak SG. Progress toward polio eradication-worldwide, 2015-2016. Morbidity and Mortality Weekly Report 2016; 65: 470-473
20. Polio Global Eradication Initiative. Polio public health emergency (http://www.polioeradication.org/Keycountries/ PolioEmergency.aspx). Accessed 30 May 2016
21. Yates MV, Gerba CP, Kelley LM. Virus persistence in groundwater. Applied and Environmental Microbiology 1985; 49: 778-781
22. Yorke JA, et al. Seasonality and the requirements for perpetuation and eradication of viruses in populations. American Journal of Epidemiology 1979; 109: 103-23
23. Duintjer Tebbens RJ, Thompson KM. Modeling the potential role of inactivated poliovirus vaccine to manage the risks of oral poliovirus vaccine cessation. Journal of Infectious Diseases 2014; 210 (Suppl. 1): S485-S497
24. Anis E, et al. Insidious reintroduction of wild poliovirus into Israel, 2013. Eurosurveillance 2013; 18: pii = 20586
25. Kaliner E, et al. The Israeli public health response to wild poliovirus importation. Lancet Infectious Diseases 2015; 15: 1236-1242
26. Asturias EJ, et al. Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an openlabel randomised controlled trial. Lancet 2016; 388: 158-169
27. Al-Hello H, et al. Highly divergent type 2 and 3 vaccinederived polioviruses isolated from sewage in Tallinn, Estonia. Journal of Virology 2013; 87: 13076-13080
28. Roivainen M, et al. Highly divergent neurovirulent vaccine-derived polioviruses of all three serotypes are recurrently detected in Finnish sewage. Eurosurveillance 2010; 15: pii = 19566
29. Conyn-Spaendonck MA, et al. Circulation of poliovirus during the poliomyelitis outbreak in The Netherlands in 1992-1993. American Journal of Epidemiology 1996; 143: 929-935
30. Eichner M, Dietz K. Eradication of poliomyelitis: when can one be sure that polio virus transmission has been terminated? American Journal of Epidemiology 1996; 143: 816-822
31. WHO. WHO statement on the meeting of the International Health Regulations Emergency Committee concerning the international spread of wild poliovirus (http://www.who.int/mediacentre/news/statements/2014/ polio-20140505/en/). Accessed 30 May 2016
32. WHO. Statement on the 10th IHR Emergency Committee regarding the international spread of poliovirus (http://www.who.int/mediacentre/news/statements/ 2016/10th-ihr-emergency/en/). Accessed 20 September 2106
33. Shaghaghi M, et al. Vaccine-derived polioviruses and children with primary immunodeficiency, Iran, 1995-2014. Emerging Infectious Diseases 2016; 22: 1712-1719
34. Duizer E, et al. Risk assessment, risk management and risk-based monitoring following a reported accidental release of poliovirus in Belgium, September to November 2014. Eurosurveillance 2016; 21: pii = 30169
35. Duintjer Tebbens RJ, Hampton LM, Thompson KM. Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of inadvertent trivalent oral poliovirus vaccine use. BMC Infectious Diseases 2016; 16: 237